OOIR: Observatory of International Research

Papers

(The H4-Index of Stroke is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association	1471
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association	550
Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities	277
Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke	228
Acute Ischemic Stroke and COVID-19	217
2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association	184
Tenecteplase Thrombolysis for Acute Ischemic Stroke	122
Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association	114
Clonal Hematopoiesis Is Associated With Higher Risk of Stroke	110
Gut Microbiota and Their Metabolites in Stroke: A Double-Edged Sword	103
Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke	100
Cancer and Embolic Stroke of Undetermined Source	99
Inflammation and Stroke Risk: A New Target for Prevention	97
Multimodal Predictive Modeling of Endovascular Treatment Outcome for Acute Ischemic Stroke Using Machine-Learning	97
Standardized Nomenclature for Modified Rankin Scale Global Disability Outcomes: Consensus Recommendations From Stroke Therapy Academic Industry Roundtable XI	95
Top Priorities for Cerebroprotective Studies—A Paradigm Shift: Report From STAIR XI	90
Large and Small Cerebral Vessel Involvement in Severe COVID-19	89
Interventions Targeting Racial/Ethnic Disparities in Stroke Prevention and Treatment	87
Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment	86
Projected Global Trends in Ischemic Stroke Incidence, Deaths and Disability-Adjusted Life Years From 2020 to 2030	85
Current Status of Endovascular Treatment for Acute Large Vessel Occlusion in China	85
Neutrophil-to-Lymphocyte Ratio Predicts Cerebral Edema and Clinical Worsening Early After Reperfusion Therapy in Stroke	83
Considerations in Addressing Social Determinants of Health to Reduce Racial/Ethnic Disparities in Stroke Outcomes in the United States	83
Cognitive Impairment After Ischemic and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association/American Stroke Association	80
Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions	78

Comprehensive Stroke Care and Outcomes	78
Role of Blood-Based Biomarkers in Ischemic Stroke Prognosis	74
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin	74
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study	73
Atrial Fibrillation Detected After Stroke and Transient Ischemic Attack: A Novel Clinical Concept Challenging Current Views	72
Vessel Wall Magnetic Resonance Imaging Biomarkers of Symptomatic Intracranial Atherosclerosis	72
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease	72
Recommendations for Regional Stroke Destination Plans in Rural, Suburban, and Urban Communities From the Prehospital Stroke System of Care Consensus Conference: A Consensus Statement From the American	70
Chronic Kidney Disease and Cerebrovascular Disease	68
Poststroke Cognitive Impairment Negatively Impacts Activity and Participation Outcomes	67
Immunodepression, Infections, and Functional Outcome in Ischemic Stroke	66
CCR5 Activation Promotes NLRP1-Dependent Neuronal Pyroptosis via CCR5/PKA/CREB Pathway After Intracerebral Hemorrhage	66
Influence of the COVID-19 Pandemic on Treatment Times for Acute Ischemic Stroke	65
Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events	64
Intracerebral Hemorrhage Incidence, Mortality, and Association With Oral Anticoagulation Use	63
Diagnosis and Management of Cerebral Venous Sinus Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia	62
Early Infarct Growth Rate Correlation With Endovascular Thrombectomy Clinical Outcomes	62
Good Clinical Outcome Decreases With Number of Retrieval Attempts in Stroke Thrombectomy	62
Early Brain Injury After Subarachnoid Hemorrhage: Incidence and Mechanisms	61
Incidence and Outcome of Aneurysmal Subarachnoid Hemorrhage	61
Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke	61
Reperfusion Without Functional Independence in Late Presentation of Stroke With Large Vessel Occlusion	61
Acute Cerebrovascular Events With COVID-19 Infection	60
Mediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled Trial	60
Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY Study	60
Mismatch Profile Influences Outcome After Mechanical Thrombectomy	59
Collateral Circulation in Thrombectomy for Stroke After 6 to 24 Hours in the DAWN Trial	58
Ischemic Stroke Occurs Less Frequently in Patients With COVID-19	58
Analysis of Nationwide Stroke Patient Care in Times of COVID-19 Pandemic in Germany	58
Endovascular Therapy of Anterior Circulation Tandem Occlusions	57
Cerebroprotection for Acute Ischemic Stroke: Looking Ahead	57
Dosage, Intensity, and Frequency of Language Therapy for Aphasia: A Systematic Review–Based, Individual Participant Data Network Meta-Analysis	56
New Insights Into Cerebrovascular Pathophysiology and Hypertension	56
Dynamic Prevalence of Sleep Disorders Following Stroke or Transient Ischemic Attack	56
Reduced Admissions for Cerebrovascular Events During COVID-19 Outbreak in Italy	56
Endothelial Dysfunction in the Brain	56
Sleep Duration and Stroke	56
Stroke Imaging Selection Modality and Endovascular Therapy Outcomes in the Early and Extended Time Windows	56